The role of matrilysin t or matrix metalloproteinase-7 (MMP-7) in cancer is extremely complex and poorly understood. In this study we investigated differential expression of MMP-7 in the epithelium and stroma of 95 paraffin-embedded renal tumor samples by immunohistochemistry and compared tumoral with normal peritumoral renal tissue. We also determined a possible correlation of the immunohistochemical findings with histological subtype, tumor grade and stage of RCC. In all areas examined MMP-7 protein expression was significantly higher in epithelium than in stroma (P<.Ot). MMP-7 was more less expressed in peritumoral normal areas than in benign epithelial neoplasias (renal papillary and oncocytomas) and RCC carcinomas, reaching the highest immunopositive reaction in chromophobe RCC subtypes, followed by conventional clear-cell and chromophilic-papillary RCC histological subtypes and the lowest levels in more aggressive RCC histotypes (spindle-cell and collecting-duct RCCs). MMP-7 reached their highest levels in high-grade and high-stage RCCs. Our observation suggests an important role of MMP-7 in the development and progression of renal cancer. The differential expression ofMMP-7 in the various histological RCC subtypes may reflect the malignant phenotype and more aggressive behavior of RCCs.
proteins including urokinase-type plasminogen activator (uPA) (10) . MMP-7 has been detected in various tumors (13) (14) (15) (16) (17) and is an important marker in human cancer progression, in tumor generation and growth (18) (19) (20) (21) (22) (23) (24) (25) (26) as well as in many other fundamental processes, such as epithelial repair and host defense (27) . The expression of MMP-7 has been poorly investigated in human RCC (28) (29) . In their study describing the expression of MMPs in various RCC subtypes, Hagemann et al (8) described neither the distribution nor the localization of MMP-7.
In this study we therefore investigated the localization, distribution and intensity of MMP-7 levels in the epithelium and stroma of normal peritumoral and neoplastic areas of 95 human renal epithelial tumors by immunohistochemistry, assessing MMP-7 protein levels by computer-assisted image analysis in the various RCC histological subtypes, and investigated the association of MMP-7 protein levels with histological grade and tumornode-metastasis (TNM) pathological stage.
MATERIALS AND METHODS

Tumor Samples
Ninety-five formalin-fixed, paraffin-embedded renal specimens were obtained from 95 patients (age range 51 to 88 years, mean age 68.11 years) who had undergone total nephrectomy for primary RCC in the Department of Urology "U. Bracci", University "La Sapienza", Rome (Italy) from 1997 to 2003. Tumors were classified, graded and staged according to the RCC classification of the American Joint Committee on Cancer 2002 (30) and the WHO 2004 (31) . Of the 95 tumors studied, 10 (10.52%) tumors showed the morphological features of benign epithelial tumors (4 papillary adenomas and 6 oncocytomas). The remaining 85 tumors (94.45%) were RCCs: 56 (65.88%) were clearcell, 13 (15.29%) chromophilic-papillary renal cell, 9 (10.58%) chromophobe-cell, 2 (2.35%) spindle-cell and 5 (5.88%) collecting-duct carcinoma subtypes. According to histological grading (32), 23/85 (27.05%) were grade I, 37/85 (43.52%) grade" and 25/85 (29.41%) grade III/IV. According to TNM pathological staging 32/85 (37.64%) tumors were pTI, 14/ 85 (16.47%) pT2, and 39/85 (45.88%) pT3.
Immunohistochemical (IHC) analysis
Two serial sections (3-f.lm thick) from renal blocks were cut onto slides coated with 3-aminopropyl-ethylxylene (Sigma-Aldrich, S.R.L, Milan, Italy), microwaved for 5 minutes at 750 W (two cycles) and stained using the primary mouse monoclonal antibody anti-MMP-7 (Matilysin/PUMP-I)(clone 10-2) IgG 2b fraction (supplied by Chemicon International, Inc), which reacts with a proactive and active form of human MMP-7, at I: 100 dilution and 4°C overnight incubation by the the avidinbiotin-peroxidase complex (ABC) method (reagents from Dako S.p.A., Milan, Italy), as previously reported (7) . All reactions included appropriate positive controls (breast tissue) and negative controls (the primary antibody was replaced by normal swine serum).
Immunohistochemical evaluation by computerassisted image analysis (IHC)
To quantify MMP-7 immunoreactivity in tissue sections, and reduce operator subjectivity, we used computer-assisted image analysis. Three representative areas of each sample (assessed by IHC) were randomly selected for each tumor tissue sample from the normal tissue adjacent to tumoral areas and RCC under a light microscope (Olympus Uplan FI [20x objective]), and captured with a digital camera (Nikon). Areas of interest were quantified with IMAGE-Pro Plus 4.5 software (Media Cybernetics, Silver Spring, MD, USA) using the histogram function of the software, as already described (7) . For each field, the number of positive areas was expressed as a fraction of the epitheliumstroma area (positive areas divided by the overall field area). For each slide, the mean+SE of colorPercent area (ColorPercent=ColorArea/tissueAreax I00) was calculated.
Statistical analysis
The results are reported as mean ± SE and expressed in arbitrary densitometric units. The data were analyzed by Multistat program (Biosoft, Cambridge, 1988). Chisquare analysis and Student's t test were used to test differences in the percentage of tumors expressing MMP-7 in epithelium and stroma of normal peritumoral and tumoral areas. Chi-square analysis and Student's t test were also used to determine the association ofMMP ligand levels with histological grading and TNM pathological stages. P values less than 0.05 were considered to indicate statistical significance.
RESULTS
In the 95 renal tumors examined, MMP-7 protein was significantly more strongly expressed in the epithelium than in the stroma of normal tissue adjacent to tumoral areas and tumoral tissue (P=O.0022 and P=O.OOOI by chi-square test) ( Table I) In the epithelium and stroma MMP-7 expression was higher in tumoral than in normal renal tissue. In the tumors, MMP-7 epithelial levels were significantly higher than stromal levels (P<.OI, by chisquare test). B) peritumoral normal renal paren chyma showingfocal and moderate-to-strong MMP-7 immunoreactivity in the cytoplasm ofrenal epithelial proximal tubules (red arrows), patchy immunostaining in renal corpuscles (mesangial cells and podocytes) and scarce and very weak MMP-7 immunostaining in the stroma . C) oncocytoma showing diffuse moderate MMP-7 immunoreactivity, localized in the cytoplasm ofoncocytic cells. and scarce immunoreacti vity in a loose hypocellularfibrou s stroma, but strong in endothelial cells (black arrow) (ABCX400). oncocytomas) with RCCs, we found significantly increased MMP-7 levels only in the epithelial compartment of RCCs (33.59±O.99 vs 22.19±O.81; P=O.0314 by Student's t tests) ( Fig. lA) . Epithelial and stromal MMP-7 expression was significantly higher in renal tumoral tissue (33.59±O.99 and IO.09±O.90) than in peritumoral normal kidney (22.19±O .81 and 6. I8±O.50) (P=O.OOO I and P=O.0026 by chi-square test) ( Fig IA) . Dysplastic changes in normal peritumoral tubules were identified in 10 of the 95 (9.5%) samples investigated. MMP-7 showed cytoplasmic immunoreactivity. Immunostaining patterns of expression differed in normal peritumoral tissue and kidney tumor. In normal peritumoral kidney, immunoreactivity for MMP-7 was distributed in renal tubules and corpuscles. Renal tubules showed diffuse, moderate to weak MMP -7 immunoreactivity, localized in the cytoplasm of the epithelium lining the proximal and distal convoluted tubules and collecting duct. In renal corpuscles, the distribution was patchy and MMP-7 was weakly expressed in the mesangial cells, podocytes and Bowman's capsule ofglomerules ( Fig.  I B) . In the few areas of dysplastic tubules adjacent to RCC and in benign epithelial renal tumors (renal papillary and oncocytomas), MMP-7 protein levels were higher-than in the normal peritumoral tissue , reaching significance only in the stroma of tumoral tissue (P=O.006, by chi-square test) (Table II ; Fig  lA) .
In malignant epithelial renal tumors, the immunohistochemical analysis of RCCs showed diffuse, moderate-to-strong cytoplasmic staining for MMP-7 in accordance with the histological RCC subtypes (Fig. 2C , D, E, F). Whereas there was no significant difference in MMP-7 expression between clear-cell, papillary-chromophilic or chromophobic RCCs, the percentage area stained for MMP-7 was significantly lower in spindle cell and collecting-duct than in clear-cell, chromophilic and chromophobic RCC subtypes either in tumoral or peritumoral normal areas. Clear-cell and chromophobic RCC subtypes contained significantly higher MMP-7 levels than spindle-cell and collecting-duct subtypes in the epithelium of malignant (P<.O I) and surrounding non-malignant tissue (P::;.05). Papillarychromophilic and collecting-duct RCC subtypes contained higher MMP-7 levels than spindle-cell RCC only in perineoplastic normal tissue (P<.05) ( Table 11 and Fig. 2A and B) . MMP-7 expression in epithelial and interstitial renal tissue reached significantly higher levels in high-grade (grade III/IV) than in lower-grade (grade 11 or I) RCC (P=0.024 and P= 0.00001 by Student's t test). The epithelium ofadvanced stage (pT3) tumors contained significantly higher levels of MMP-7 than lower stage (pTl) tumors (P=O.OOIO by Student t test) (Table III) .
DISCUSSION
In this in vivo immunohistochemical study we found strong MMP-7 expression in the epithelium and weaker expression in the stroma of normal peritumoral and neoplastic areas of the human renal epithelial tumors studied. Of the 95 RCCs investigated, 93 expressed MMP-7.
In line with previous data on the localization of MMP-7 expression in human (7) and mouse tissue (28, 33) , we detected MMP-7 staining mainly in the cytoplasm of the epithelial cancer cells and less in interstitial or inflammatory cells. We also detected significantly higher-levels in the epithelial tissue of malignant and non-malignant perineoplastic areas than in the stroma. This localization agrees with previous immunohistochemical and in situ hybridization studies in RCCs (9-10) and other tumors (35) , including breast (13), describing MMP-7 localized specifically in the tumor cells and less in the stroma, but disagrees with Heppner et at (36) who found MMP-7 focally localized in the fibroblasts of breast tumor cells. A possible reason why MMP-7 tissue localization differs might be RCC heterogeneity. The divergent findings in the various studies may also be partly explained by differences between the antibodies used in immunohistochemistry. In this study, we used an antibody against the MMP-7 profonn, recognizing both the proactive (inactive) and active forms of MMP-7. The intracellular and extracellular localization of MMP-7 we describe in human RCCs suggests that the secretory protein MMP-7 is produced in epithelial cells and then secreted into the extracellular matrix. An interesting finding on the distribution of MMP-7 expression in the renal epithelial tumor samples evaluated in this immunohistochemical study was that MMP-7 levels were higher in dysplastic tubules and in benign epithelial neoplasias (renal papillary and oncocytomas) than in the surrounding normal renal tissue. This specific distribution pattern suggests that MMP-7 is produced by norinal renal epithelial cells and kept by these cells at low basal levels. In line with other reports in prostatic neoplasia (7, 29) and in gastric cancer (25) , in RCCs, we found that MMP-7 was expressed not only in cancer cells, but also in dysplastic and benign lesions, indicating that MMP-7 was already apparent as a precancerous event. This constitutive pattern of expression indicates that rather than intervening merely in the remodelling process, as well as having a well-characterized role in tumor invasion, MMP-7, probably as in prostate cancer (7) , may also be important in initiating or promoting RCCs. MMP-7 staining differed significantly in intensity among the various RCC histological subtypes. We detected the highest MMP-7 protein levels in the chromophobic RCC subtypes, followed by the conventional clear-cell and chromophilic-papillary RCC subtypes, and the lowest levels in the highly aggressive spindle-cell and collecting-duct RCC types studied. Whereas we found no significant difference in MMP-7 expression between clearcell and chromophilic-papillary or chromophobic RCC subtypes, the percentage area stained for MMP-7 was significantly lower in spindle-cell and collecting-duct than in clear-cell, chromophilic and chromophobic RCC subtypes both in tumoral and peritumoral normal areas (P<OI by chi-square test). In a study investigating mRNA expression of MMPs in RCC subtypes, Hagemann et al (8) showed stronger expression of most MMPs in clear-cell than in the papillary RCC, with the exception of MMP-2 and MMP-14 for which they found no detectable differences. In the same study, clear-cell RCCs were associated with a high mRNA MMP-9 concentration, whereas chromophilic-papillary-cell RCCs exhibited higher mRNA MMP-l expression in malignant and non-malignant tissues. These different results may be explained by the different techniques used. Unlike the immunohistochemical technique we used, the quantitative RT-PCR technique Hagermann et al used for measuring mRNA expression, provided no information on the amount of protein expressed, in particular of MMP-7 protein. Studies conducted by others (9-10) reported that chromophilic-papillary RCC showed significantly stronger MMP-2 expression than clear-cell RCC, whereas the highly aggressive sarcomatoid RCC displayed the least immunoreactivity among the studied types.
The higher MMP-7 protein expression we found in the chromophobic RCC than in clear-cell and chromophilic-papillary RCC subtypes confirms that the chromophobic RCC type is the least aggressive among all RCC types. In contrast, the lower MMP-7 protein expression we found in spindle-cell and collecting-duct RCC subtypes indicate that these RCCs are more aggressive than the other types. Hence, our findings along with current knowledge suggest that MMP-7 is associated with the malignant RCC phenotype and indicate that MMP-7 may be a marker of better differentiation and a relatively favorable prognosis. Whether it acts to inhibit tumor spreading is an interesting question for future studies to clarify. Our study agrees with Leinonen et al (37) , who founded high MMP-7 expression in less aggressive non small cell lung cancer.
In accordance with the only two similar previous studies (8, 29) , we detected a significant correlation between high histological grade and advanced tumor stages. This increased expression of MMP-7 in highgrade and advanced-stage RCC, as reported in many other tumors including astrocytoma (17) , gastric (14, (24) (25) 38) , colon (26) , esophageal (23) , ovarian (20) , squamous cell (19) and prostate (7, 14, 20) and lung (37, 39) cancers, may be associated with increased depth of tumor invasion and metastasis.
In conclusion, MMP-7 expression in human RCCs differs according to the histological type, grade and stage, suggesting that MMP-7 may be associated with the histomorphologica1 features of RCC subtypes and their respective biological behavior.
